High urinary cAMP in hypertensives despite careful drug treatment--an epidemiological study from the Dalby population

Area of Science:

• Biochemistry
• Cardiovascular Medicine
• Endocrinology

Background:

• Hypertension is a global health concern with complex underlying mechanisms.
• Previous research suggests potential links between electrolyte balance, hormonal regulation, and blood pressure control.

Purpose of the Study:

• To investigate the relationship between serum calcium (S-Ca), plasma parathyroid hormone (P-PTH), and hypertension.
• To compare levels of urinary cyclic-adenosine monophosphate (U-cAMP) and plasma cAMP (P-cAMP) in hypertensive patients and normotensive controls.

Main Methods:

• A population-based, cross-sectional study comparing treated hypertensives (n=391) with normotensive controls (n=328).
• Measurements included serum calcium (S-Ca), serum magnesium (S-Mg), plasma parathyroid hormone (P-PTH), urinary cyclic-adenosine monophosphate (U-cAMP), and plasma cAMP (P-cAMP).
• Multivariate analyses were used to assess correlations, including with adrenaline levels.

Main Results:

• Hypertensives exhibited significantly higher U-cAMP (P < 0.001), S-Ca (P < 0.001), and lower S-Mg (P < 0.001) compared to controls.
• Elevated U-cAMP levels correlated with adrenaline.
• These biochemical differences were observed irrespective of antihypertensive drug treatment or achieved blood pressure levels.
• The observed differences in S-Ca and S-Mg were not attributable to thiazide medication.

Conclusions:

• Despite effective blood pressure management, significant disparities in S-Ca, S-Mg, and U-cAMP persist between hypertensive individuals and normotensive controls.
• These findings suggest underlying biochemical alterations in hypertension that are not fully normalized by current treatment strategies.
• Further research is warranted to elucidate the specific roles of calcium, magnesium, and cAMP in the pathophysiology of hypertension.